Récepteur dopaminergique D1 < Récepteur dopaminergique D2 < Récepteur dopaminergique D3

Facettes :

List of bibliographic references indexed by Récepteur dopaminergique D2

Number of relevant bibliographic references: 55.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
001038 (2013)	James B. Koprich [Canada] ; Philippe Huot [Canada] ; Susan H. Fox [Canada] ; Keith Jarvie [Canada] ; Anthony E. Lang [Canada] ; Philip Seeman [Canada] ; Jonathan M. Brotchie [Canada]	The effects of fast-off-D2 receptor antagonism on L-DOPA-induced dyskinesia and psychosis in parkinsonian macaques
001F26 (2009)	Isabelle Boileau [Canada, Niger] ; Mark Guttman [Canada] ; Pablo Rusjan [Canada] ; John R. Adams [Canada] ; Sylvain Houle [Canada] ; Junchao Tong [Canada] ; Oleh Hornykiewicz [Autriche] ; Yoshiaki Furukawa [Canada] ; Alan A. Wilson [Canada] ; Shitij Kapur [Canada] ; Stephen J. Kish [Canada]	Decreased binding of the D3 dopamine receptor-preferring ligand [11C]-(+)-PHNO in drug-naïve Parkinson's disease
002055 (2009)	Desirae M. Haluk [Canada] ; Stan B. Floresco [Canada]	Ventral Striatal Dopamine Modulation of Different Forms of Behavioral Flexibility
002078 (2009)	Pierre-Luc Tremblay [Canada] ; Marc-Andre Bedard [Canada] ; Maxime Levesque [Canada] ; Mark Chebli [Canada] ; Maxime Parent [Canada] ; Richard Courtemanche [Canada] ; Pierre J. Blanchet [Canada]	Motor sequence learning in primate : Role of the D2 receptor in movement chunking during consolidation
002101 (2009)	Stuart W. S. Macdonald [Canada, Suède] ; Simon Cervenka [Suède] ; Lars Farde [Suède] ; Lars Nyberg [Suède] ; Lars B Ckman [Suède]	Extrastriatal dopamine D2 receptor binding modulates intraindividual variability in episodic recognition and executive functioning
002105 (2009)	Jennifer R. St. Onge [Canada] ; Stan B. Floresco [Canada]	Dopaminergic Modulation of Risk-Based Decision Making
002107 (2009)	Vesna Sossi [Canada] ; Katherine Dinelle [Canada] ; Geoffrey J. Topping [Canada] ; James E. Holden [États-Unis] ; Doris Doudet [Canada] ; Michael Schulzer [Canada] ; Thomas J. Ruth [Canada] ; A. Jon Stoessl [Canada] ; Raul De La Fuente-Femandez [Canada]	Dopamine transporter relation to levodopa-derived synaptic dopamine in a rat model of Parkinson's : an in vivo imaging study
002947 (2006)	Naomi P. Visanji [Canada] ; Mark J. Millan [France] ; Jonathan M. Brotchie [Canada]	Actions at sites other than D3 receptors mediate the effects of BP897 on L-DOPA-induced hyperactivity in monoamine-depleted rats
002D05 (2004)	M. A. Silverdale [Royaume-Uni] ; S. L. Nicholson [Royaume-Uni] ; P. Ravenscroft [Royaume-Uni] ; A. R. Crossman [Royaume-Uni] ; M. J. Millan [France] ; J. M. Brotchie [Canada]	Selective blockade of D3 dopamine receptors enhances the anti-parkinsonian properties of ropinirole and levodopa in the MPTP-lesioned primate
002E27 (2003)	Alan L. Whone [Royaume-Uni] ; Ray L. Watts [États-Unis] ; A. Jon Stoessl [Canada] ; Margaret Davis [États-Unis] ; Sven Reske [Allemagne] ; Claude Nahmias ; Anthony E. Lang [Canada] ; Olivier Rascol [France] ; Maria J. Ribeiro [France] ; Philippe Remy [France] ; Werner Poewe [Autriche] ; Robert A. Hauser [États-Unis] ; David J. Brooks [Royaume-Uni]	Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL‐PET study
002F06 (2003)	K. Fuxe [Suède] ; L. F. Agnati [Italie] ; K. Jacobsen [Canada] ; J. Hillion [États-Unis] ; M. Canals [Espagne] ; M. Torvinen [Suède] ; B. Tinner-Staines [Canada] ; W. Staines [Canada] ; D. Rosin [États-Unis] ; A. Terasmaa [Suède] ; P. Popoli [Italie] ; G. Leo [Italie] ; V. Vergoni [Italie] ; C. Lluis [Espagne] ; F. Ciruela [Espagne] ; R. Franco [Espagne] ; S. Ferre [États-Unis]	Receptor heteromerization in adenosine A2A receptor signaling: Relevance for striatal function and Parkinson's disease
002F43 (2003)	Michael Iskedjian [Canada] ; Thomas R. Einarson [Canada]	Cost analysis of ropinirole versus levodopa in the treatment of Parkinson's disease
002F45 (2003)	Mahyar Etminan [Canada] ; Sudeep Gill [Canada] ; Ali Samii [États-Unis]	Comparison of the risk of adverse events with Pramipexole and ropinirole in patients with Parkinson's disease a meta-analysis
003032 (2002)	Yun J. Kim [Canada] ; Masanori Ichise [Canada] ; James R. Ballinger [Canada] ; Douglas Vines [Canada] ; Sean S. Erami [Canada] ; Tatsuro Tatschida [Canada] ; Anthony E. Lang [Canada]	Combination of dopamine transporter and D2 receptor SPECT in the diagnostic evaluation of PD, MSA, and PSP
003078 (2002)	James E. Holden [États-Unis] ; Salma Jivan [Canada] ; Thomas J. Ruth [Canada] ; Doris J. Doudet [Canada]	In vivo receptor assay with multiple ligand concentrations: An equilibrium approach
003091 (2002)	Raul De La Fuente-Fernandez [Canada] ; Anthony G. Phillips [Canada] ; Mariangela Zamburlini [Canada] ; Vesna Sossi [Canada] ; Donald B. Calne [Canada] ; Thomas J. Ruth [Canada] ; A. Jon Stoessl [Canada]	Dopamine release in human ventral striatum and expectation of reward
003092 (2002)	C. E. Clarke [Royaume-Uni] ; M. Guttman [Canada]	Dopamine agonist monotherapy in Parkinson's disease
003103 (2002)	Frédéric Calon [Canada] ; Marc Morissette [Canada] ; Othman Ghribi [Canada] ; Martin Goulet [Canada] ; Richard Grondin [Canada] ; Pierre J. Blanchet [Canada] ; Paul J. Bedard [Canada] ; Thérèse Di Paolo [Canada]	Alteration of glutamate receptors in the striatum of dyskinetic 1 -methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkeys following dopamine agonist treatment
003159 (2001)	J. Thomas Hutton [États-Unis] ; Leo Verhagen Metman [États-Unis] ; Thomas N. Chase [États-Unis] ; Jorge L. Juncos [États-Unis] ; William C. Koller [États-Unis] ; Rajesh Pahwa [États-Unis] ; Peter A. Lewitt [États-Unis] ; Ali Samii [Canada] ; Joseph K. C. Tsui [Canada] ; Donald B. Calne [Canada] ; Cheryl H. Waters [États-Unis] ; Vincent P. Calabrese [États-Unis] ; James P. Bennett [États-Unis] ; Richard Barrett [États-Unis] ; Jerry L. Morris [États-Unis]	Transdermal dopaminergic D2 receptor agonist therapy in Parkinson's disease with N‐0923 TDS: A double‐blind, placebo‐controlled study
003310 (2001)	Mahyar Etminan [Canada] ; Ali Samii [États-Unis] ; Bahi Takkouche [Espagne] ; Paula A. Rochon [Canada]	Increased risk of somnolence with the new dopamine agonists in Patients with Parkinson's disease: A meta-analysis of randomised controlled trials
003332 (2001)	ABDALLAH HADJ TAHAR [Canada] ; Anna Ekesbo [Suède] ; Laurent Gregoire [Canada] ; Evelyne Bangassoro [Canada] ; Kjell A. Svensson [États-Unis] ; Joakim Tedroff [Suède] ; Paul J. Bedard [Canada]	Effects of acute and repeated treatment with a novel dopamine D2 receptor ligand on L-DOPA-induced dyskinesias in MPTP monkeys

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/PascalFr.i -k "Récepteur dopaminergique D2" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/PascalFr.i  \
                -Sk "Récepteur dopaminergique D2" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    PascalFr.i
   |clé=    Récepteur dopaminergique D2
}}

---

This area was generated with Dilib version V0.6.29. Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022